Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey MD Tanriover, HL Doğanay, M Akova, HR Güner, A Azap, S Akhan, ... The Lancet 398 (10296), 213-222, 2021 | 934 | 2021 |
Antifungal susceptibility and risk factors in patients with candidemia C Mermutluoglu, O Deveci, S Dayan, E Aslan, F Bozkurt, R Tekin The Eurasian journal of medicine 48 (3), 199, 2016 | 33 | 2016 |
Evaluation of inflammatory and hematological parameters in patients diagnosed with COVID-19 Ç Mermutluoğlu, R Dursun, F Aktar, S Dayan, MK Çelen, AK Kadiroğlu, ... The Journal of Infection in Developing Countries 16 (10), 1564-1569, 2022 | 7 | 2022 |
Which COVID-19 patients die in intensive care unit (icu) in Turkey R Dursun, C Mermutluoglu, F Aktar, R Tekin, M Kuyumcu, İ Yildiz, ... Dicle Tıp Dergisi 49 (1), 85-91, 2022 | 5 | 2022 |
Evulation of prolidase enzyme, and galectin levels as a marker for fibrosis in patients with chronic hepatitis B. Ç Mermutluoğlu, R Tekin, RC Tekin, S Tekin, REC Erkan, Ö Deveci, ... European Review for Medical & Pharmacological Sciences 26 (24), 2022 | 3 | 2022 |
Leptospirosis accompanying COVID-19: A case report Y Demir, Ç Mermutluoğlu Journal of Clinical Trials and Experimental Investigations 1 (2), 60-63, 2022 | 3 | 2022 |
Evaluation of elabela, visfatin, and chemerin levels as inflammation biomarkers in COVID-19 C MERMUTLUOGLU, R TEKIN European Review for Medical and Pharmacological Sciences 27 (22), 11180-11184, 2023 | 2 | 2023 |
Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data T DAMAR ÇAKIRCA, T Yamazhan, F AKGÜL, B KURTARAN, ... Viral Hepatit Dergisi-Viral Hepatitis Journal 29, 2023 | 1 | 2023 |
COVID-19 Erişkin Hasta Yönetimi Ç Mermutluoğlu Dicle Tıp Dergisi 48, 114-121, 2021 | 1 | 2021 |
A Novel Predictor of Vegetation Size in Infective Endocarditis: MAPH Score Ç Mermutluoğlu, T Güzel, TT Kış Eastern Journal Of Medicine 29 (2), 201-207, 2024 | | 2024 |
Evaluation of chronic hepatitis B patients who voluntarily discontinued oral antiviral therapy: is there an answer to the controversial topic? E Arslan, Y Yildiz, Ö Karaşahin, Y Demir, ÇT Mermutluoğlu, G Ünlü, ... European Journal of Gastroenterology & Hepatology 36 (4), 438-444, 2024 | | 2024 |
The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study D Başkol Elik, Ş Kaya, S Alkan, T Demirdal, A Sener, S Kaya, ... Scientific Reports 14 (1), 1-12, 2024 | | 2024 |
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey M Çelen, B Sengel, S Kaya, N Demirturk, A Azap, H Pullukçu, E Eroglu, ... Journal of Infection in Developing Countries 18 (3), 2024 | | 2024 |
Bruselloz Hastalarının D vitamini, Ferritin, Folik Asit ve Biyokimyasal Düzeylerinin Değerlendirilmesi İ Sabancılar, İH Şahin, Ç Mermutluoğlu, H Temiz Dicle Tıp Dergisi 50 (4), 587-593, 2023 | | 2023 |
The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19 Y Yıldız, HS Özger, A Acar, A Seremet-Keskin, UD Binay, G Ünlü, ... Infectious Diseases & Clinical Microbiology 5 (2), 118, 2023 | | 2023 |
Analysis of Risk Factors Associated with Candidemia Among Patients with or without COVID-19 in Intensive Care Units During the Pandemic Process: A Multicenter Study M Gözükara, Y Uygun Kizmaz, Y DEMİR, M Törüyenler Coşkunpınar, ... Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 28 (3), 2023 | | 2023 |
Klinik Örneklerden İzole Edilen Karbapenem Dirençli Klebsiella pneumoniae ve Escherichia coli Suşlarında Antibiyotik Duyarlılıklarının Araştırılması: Kapsamlı Bir Sağlık … Ç Mermutluoğlu, EZ Çiftçi, N Özcan, S Dayan Van Tıp Dergisi 30 (4), 374-381, 2023 | | 2023 |
Immunsupressif Tedavi Gereksinimi Olan İzole AntiHBC Ig G pozitif Hepatit B’li Hastalarda MAFLD Varlığının Saptanması Ç Mermutluoğlu, M Celen Van Tıp Dergisi 30 (4), 396-400, 2023 | | 2023 |
CANNABINOIDS IN THE TREATMENT OF INFECTIOUS DISEASES ÇTM , FATMA MERAL İNCE ORIENT, 2023 | | 2023 |
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey: a retrospective, cross-sectional chart review (Lost-C Study) MK Çelen, BE Şengel, Ş Kaya, N Demirtürk, A Azap, H Pullukçu, E Eroğlu, ... | | 2022 |